Journal of Hospice and Palliative Care

Korean Society for Hospice and Palliative Care (한국호스피스완화의료학회)
권호 표지
DOI QR코드

DOI QR Code

Changes in Life-sustaining Treatment in Terminally Ill Cancer Patients after Signing a Do-Not-Resuscitate Order

심폐소생술금지 동의 전·후 말기암환자의 연명치료 변화

  • Kim, Hyun A (Department of Nursing, Asan Medical Center) ;
  • Park, Jeong Yun (Department of Clinical Nursing, College of Medicine, University of Ulsan)
  • 김현아 (서울아산병원 간호부) ;
  • 박정윤 (울산대학교 의과대학 임상전문간호학)
  • Received : 2016.10.24
  • Accepted : 2017.05.02
  • Published : 2017.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: This study investigated changes in life-sustaining treatments in terminally ill cancer patients after consenting to a do-not-resuscitate (DNR) order. Methods: Electronic medical records were reviewed to select terminally ill cancer patients who were treated at the oncology unit of the Asan Medical Center, a tertiary hospital in South Korea and died between January 1, 2013 and December 31, 2013. Results: The median (range) age of the 200 patients was 59 (22~89) years, and 62% (124 persons) were male. Among all patients, 83.5% were aware of their medical condition, and 47.0% of the patients had their DNR order signed by their spouses. The median of the patients' hospital stay was 15 days, and time from admission to DNR decision was 10 days. After signing a DNR order, 35.7~100% of the life-sustaining treatments that had been provided at the time of the DNR decision making were administered. The most commonly discontinued interventions were transfusion (13.5%), blood test (11.5%) and parenteral nutrition (8.5%). Conclusion: It is necessary to define the scope of life-sustaining treatments for DNR patients. Treatment guidelines should be established as well to secure terminal patients' death with dignity after their consent to a DNR order, thereby avoiding meaningless life-sustaining treatments and allowing administration of active terminal care interventions.

목적: 본 연구는 심폐소생술금지에 동의한 암환자를 대상으로 연명치료 변화를 확인하기 위해 시도된 후향적 조사연구이다. 방법: 연구대상자는 S시에 소재한 A종합병원에서 2013년 1월 1일부터 12월 31일까지 종양내과 병동에 입원치료하고 사망한 암환자로 심폐소생술금지에 동의한 250명이 선정되었으며, 이중 심폐소생술금지를 입원당일 동의하였거나(N=40) 동의 후 3일 이내 사망한(N=10) 경우는 제외하였다. 대상자의 특성과 연명치료의 변화를 의무기록을 통해 조사하였으며, 심폐소생술금지 지시 동의 전 1일과 심폐소생술금지 지시 동의 후 3일 혹은 사망시점까지 조사하여 유지, 중단, 추가로 연명의료 변화를 판정하였다. 수집된 자료는 SPSS Win 21.0 프로그램을 이용하여 분석하였다. 결과: 연구대상자는 총 200명으로, 50~59세 나이 군이 36.0%로 가장 많이 차지하였고 남자가 62%였다. 재원일은 15일이었고, 입원하여 10일되는 시점에서 심폐소생술금지에 동의하였다. 심폐소생술금지에 동의 후 35.7~100%에서 연명치료가 계속 유지되었다. 인공호흡기 치료는 중단되지 않고 100% 유지되었으며, 수혈(37%), 혈액검사(37.4%), 산소요법(23.5%) 순으로 추가되었다. 중단된 연명치료 중 가장 빈도가 높은 것은 수혈(13.5%)이었고, 다음으로 혈액검사(11.5%), 비경구성 영양제투여(8.5%) 순이었다. 결론: 심폐소생술 지시 동의 후에 대부분 연명치료는 계속되었고 중단되는 경우는 드물었다. 의료진과 가족들 간의 연명치료 범위에 대한 이견을 좁히고, 무의미한 연명치료 중단에 대한 결정을 합의하기 위한 적극적인 논의가 요구된다.

Keywords

References

  1. National Cancer Information Center [Internet]. Goyang: National Cancer Information Center; c2012 [updated 2016 Dec 20; cited 2017 Apr 28]. Available from: http://www.cancer.go.kr/mbs/cancer/subview.jsp?id=cancer_040101000000#none.
  2. Han YR, Kim IH. Attitude toward death and recognition of hospice of community dwellers. J Korean Acad Public Health Nurs 2008;22:49-61.
  3. Koh SJ, Lee KS, Hong YS, Yoo YS, Park HJ. Clinical change of terminally ill cancer patients at the end-of-life time. Korean J Hosp Palliat Care 2008;11:99-105.
  4. Jo HS, Cho OH, Yoo YS. Nurses' perception on fluid therapy for terminally ill patients. Korean J Hosp Palliat Care 2010;13:243-51.
  5. Bruera E. Hui D, Dalal S, Torres-Vigil I, Trumble J, Roosth J, et al. Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol 2013;31:111-8.
  6. Morita T, Shima Y, Miyashita M, Kimura R, Adachi I; Japan Palliative Oncology Study Group. Physician- and nurse-reported effects of intravenous hydration therapy on symptoms of terminally ill patients with cancer. J Palliat Med 2004;7:683-93. https://doi.org/10.1089/jpm.2004.7.683
  7. Chen LK, Chou YC, Hsu PS, Tsai ST, Hwang SJ, Wu BY, et al. Antibiotic prescription for fever episodes in hospice patients. Support Care Cancer 2002;10:538-41. https://doi.org/10.1007/s00520-002-0377-9
  8. Reinbolt RE, Shenk AM, White PH, Navari RM. Symptomatic treatment of infections in patients with advanced cancer receiving hospice care. J Pain Symptom Manage 2005;30:175-82. https://doi.org/10.1016/j.jpainsymman.2005.03.006
  9. Oh DY, Kim JH, Kim DW, Im SA, Kim TY, Heo DS, et al. Antibiotic use during the last days of life in cancer patients. Eur J Cancer Care (Engl) 2006;15:74-9. https://doi.org/10.1111/j.1365-2354.2005.00603.x
  10. Jeong HS, Kim DY, Song KP, Suh SY; Korean Family Medicine Palliative Medicine Research Group. Antibiotics use in infected patients with terminal stage of cancer-Based on seminar of Korean family medicine palliative medicine research group-. Korean J Hosp Palliat Care 2007;10:43-7.
  11. Helde-Frnakling M, Berggvist J, Bergman P, Biorkhem-Bergman L. Antibiotic Treatment in End-of-Life Cancer Patients-A Retrospective Observational Study at a Palliative Care Center in Sweden. Cancers (Basel) 2016;8(9). pii: E84. https://doi.org/10.3390/cancers8090084
  12. Ministry of Health and Welfare [Internet]. Sejong: Ministry of Health and Welfare; 2013 [updated 2013 Oct 14; cited 2015 Dec 18]. Available from: http://www.mohw.go.kr/front_new/al/sal0301vw.jsp?PAR_MENU_ID=04&MENU_ID=0403&CONT_SEQ=291914&page=1.
  13. Phua J, Joynt GM, Nishimura M, Deng Y, Myatra SN, Chan YH, et al. Withholding and withdrawal of life-sustaining treatments in intensive care units in Asia. JAMA Intern Med 2015;175:363-71. Erratum in: JAMA Intern Med 2015;175:1248. https://doi.org/10.1001/jamainternmed.2014.7386
  14. Guideline to withdrawal of a life-sustaining therapy [Internet]. Seoul: Korean Medical Association; Korean Academy of Medical Sciences; Korean Hospital Association; 2009 [cited 2017 Apr 28]. Available from: http://www.kams.or.kr/notice/view.php?code=news&number=277.
  15. Koh Y. Physician's role and obligation in the withdrawal of life-sustaining management. J Korean Med Assoc 2009;52:871-9. https://doi.org/10.5124/jkma.2009.52.9.871
  16. Kim DY. Medications at the end of life care for terminal cancer patients during their last admission. Korean J Hosp Palliat Care 2010;13:7-12.
  17. Yoon HM, Choi YS, Hyun JJ. Current situation on signing advance medical directives and actual life-sustaining treatment given at a University Hospital. Korean J Hosp Palliat Care 2011;14:91-100.
  18. Baker JN, Kane JR, Rai S, Howard SC, Hinds PS; PCS Research Working Group. Changes in medical care at a pediatric oncology referral center after placement of a do-not-resuscitate order. J Palliat Med 2010;13:1349-52. https://doi.org/10.1089/jpm.2010.0177
  19. Baek MS, Koh Y, Hong SB, Lim CM, Huh JW. Effect of timing of do-not-resuscitate orders on the clinical outcome of critically Ill patients. Korean J Crit Care Med 2016;31:229-35. https://doi.org/10.4266/kjccm.2016.00178
  20. Farber NJ, Simpson P, Salam T, Collier VU, Weiner J, Boyer EG. Physicians' decisions to withhold and withdraw life-sustaining treatment. Arch Intern Med 2006;166:560-4. https://doi.org/10.1001/archinte.166.5.560
  21. Rao JK, Alongi J, Anderson LA, Jenkins L, Stokes GA, Kane M. Development of public health priorities for end-of-life initiatives. Am J Prev Med 2005;29:453-60. https://doi.org/10.1016/j.amepre.2005.08.014
  22. Koh Y. Current status of end-of-life care in Korean hospitals. J Korean Med Assoc 2012;55:1171-7. https://doi.org/10.5124/jkma.2012.55.12.1171
  23. Lee JR, Lee JK, Hwang SJ, Kim JE, Chung JI, Kim SY. Doctors' perception and referral barriers toward palliative care for advanced cancer patients. Korean J Hosp Palliat Care 2012;15:10-7.

Cited by

  1. Comparison of Life-Sustaining Treatment in Terminal Cancer Patients between a Cancer and Hospice Unit after Do-Not-Resuscitate Orders vol.18, pp.4, 2018, https://doi.org/10.5388/aon.2018.18.4.198
  2. 국내 일개 2차 병원의 암환자 치료 실태 vol.21, pp.3, 2018, https://doi.org/10.14475/kjhpc.2018.21.3.84
  3. Implementation of Antimicrobial Stewardship Programs in End-of-Life Care vol.51, pp.2, 2017, https://doi.org/10.3947/ic.2019.51.2.89
  4. 성인의 심폐소생술 금지(DNR)에 대한 인식 및 태도에 대한 조사 연구 vol.10, pp.6, 2019, https://doi.org/10.15207/jkcs.2019.10.6.393
  5. 만성 심폐질환을 가진 말기 노인 환자의 연명의료 의사결정의 번복 및 관련 요인 vol.49, pp.3, 2017, https://doi.org/10.4040/jkan.2019.49.3.329
  6. 만성 심폐질환을 가진 말기 노인환자의 연명의료결정 전후 완화간호의 제공 vol.11, pp.1, 2021, https://doi.org/10.22156/cs4smb.2021.11.01.045
  7. 암환자의 사전연명의료의향서 지식과 좋은 죽음 인식이 연명의료중단 태도에 미치는 영향 vol.22, pp.2, 2017, https://doi.org/10.5762/kais.2021.22.2.539
  8. Analysis of high-intensity care in intensive care units and its cost at the end of life among older people in South Korea between 2016 and 2019: a cross-sectional study of the health insurance review vol.11, pp.8, 2017, https://doi.org/10.1136/bmjopen-2021-049711